Cardiotoxicity of Azithromycin in COVID-19: An Overall Proportion Meta-Analysis
Abstract
Share and Cite
Farmakis, I.; Minopoulou, I.; Giannakoulas, G.; Boutou, A. Cardiotoxicity of Azithromycin in COVID-19: An Overall Proportion Meta-Analysis. Adv. Respir. Med. 2022, 90, 171-182. https://doi.org/10.5603/ARM.a2022.0022
Farmakis I, Minopoulou I, Giannakoulas G, Boutou A. Cardiotoxicity of Azithromycin in COVID-19: An Overall Proportion Meta-Analysis. Advances in Respiratory Medicine. 2022; 90(3):171-182. https://doi.org/10.5603/ARM.a2022.0022
Chicago/Turabian StyleFarmakis, Ioannis, Ioanna Minopoulou, George Giannakoulas, and Afroditi Boutou. 2022. "Cardiotoxicity of Azithromycin in COVID-19: An Overall Proportion Meta-Analysis" Advances in Respiratory Medicine 90, no. 3: 171-182. https://doi.org/10.5603/ARM.a2022.0022